Loading…
Loading…
Qualys (QLYS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Qualys (QLYS) reported earnings 30 days ago. What's next for the stock?
Rising cyber threats and growing AI adoption create long-term growth opportunities for cybersecurity companies with AI-powered platforms.
Canada Pension Plan Investment Board acquired a new position in Qualys, Inc. (NASDAQ: QLYS) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 9,200 shares of the software maker's stock, valued at approximately $1,265,000. Other institutional investors and hedge funds have also
Qualys delivered Q2 2026 results above consensus, maintaining solid revenue growth, expanding margins, and robust cash generation. QLYS benefits from GenAI-driven threat complexity, a healthy pipeline, and the launch of QFlex, supporting improved net dollar retention and customer wallet share. Management raised FY26 revenue guidance by 1.5% and EPS by 3.6%, reflecting confidence in pipeline conversion and operational execution.
Deutsche Bank AG purchased a new stake in shares of Qualys, Inc. (NASDAQ: QLYS) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 92,118 shares of the software maker's stock, valued at approximately $12,665,000. Deutsche Bank AG owned approximately 0.27% of Qualys at the end of
In a blog update, Claude commented on its efforts to help more teams use frontier capabilities for cyber defense. "Claude Mythos 5 is now available in Claude Security, and coming soon to partners' cyber defense tools. We're also launching a $35M fund to help secure open-source software and sharing plans to expand our Cyber Verification Program. The riskiest behavior occurs when a user has direct access to a model, where a malicious actor can try to steer it toward harmful uses. But if users can only receive specific outputs, such as a patch for a vulnerability or a security alert, that risk is much lower. The changes we're announcing give users greater access to the defensive results, while maintaining appropriate guardrails around direct access to the model: Claude Mythos 5 integration into the tools defenders rely on. We're working with our cybersecurity technology and services partners to integrate Claude Mythos 5 into the products and services defenders already use to secure their software. Claude Security scans can now run on Claude Mythos 5. Customers on Claude Enterprise plans can now run our most capable model in Claude Security, using it to scan their codebases for security vulnerabilities and suggest patches.$35M in credits for open-source security. Our new Defender Advantage Fund will provide $35M in credits to organizations working to patch vulnerabilities in open-source projects, automate parts of the process of scanning and patching open-source software, and experiment with new security approaches. Expanding our Cyber Verification Program. The program already gives vetted defenders reduced safeguards on Opus and Sonnet models. In the coming weeks, we will expand this program to include broader dual-use capabilities on Opus and Sonnet, with Mythos-class access to follow... We will continue to work with government partners, organizations, open-source maintainers, and the broader industry to build the resilient cyber infrastructure today's highly capable AI models demand." Publicly traded companies in the space include Check Point (CHKP), CrowdStrike (CRWD), CyberArk (CYBR), F5 (FFIV), Fortinet (FTNT), Gen Digital (GEN), Okta (OKTA), Palo Alto Networks (PANW) and Qualys (QLYS). <a class="reference_link" href="https://claude.com/blog/bringing-claude-mythos-5-to-more-defenders" target="new">Reference Link</a>
Shares of Qualys, Inc. (NASDAQ: QLYS - Get Free Report) have been given a consensus rating of "Hold" by the seventeen research firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating, three have assigned a buy rating and two have